Cargando…

Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study

BACKGROUND: This study aimed to compare ocular surface parameter changes in active and inactive thyroid eye disease (TED) patients and controls. METHODS: This is an observational clinical study that included 60 eyes divided into three groups following clinical activity score (CAS) assessment. The fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Allam, Ibrahim Y, Lazreg, Sihem, Shafik Shaheen, Mohamed, Doheim, Mohamed Fahmy, Mohammed, Mai A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214558/
https://www.ncbi.nlm.nih.gov/pubmed/34163131
http://dx.doi.org/10.2147/OPTH.S317708
_version_ 1783710089289400320
author Allam, Ibrahim Y
Lazreg, Sihem
Shafik Shaheen, Mohamed
Doheim, Mohamed Fahmy
Mohammed, Mai A
author_facet Allam, Ibrahim Y
Lazreg, Sihem
Shafik Shaheen, Mohamed
Doheim, Mohamed Fahmy
Mohammed, Mai A
author_sort Allam, Ibrahim Y
collection PubMed
description BACKGROUND: This study aimed to compare ocular surface parameter changes in active and inactive thyroid eye disease (TED) patients and controls. METHODS: This is an observational clinical study that included 60 eyes divided into three groups following clinical activity score (CAS) assessment. The first group (Group A) comprised 20 eyes with active TED (CAS score ≥3/7), while the second group (Group B) comprised 20 eyes with inactive TED (CAS score <3/7) and the third group (Group C) comprised 20 eyes of controls without dry eye manifestations. The palpebral fissure height, degree of proptosis, degree of lagophthalmos, ocular surface disease index (OSDI), Schirmer test without anesthesia, corneal fluorescein staining (CFS), non-invasive tear break-up time (NITBUT), tear meniscus height (TMH), lipid layer thickness (LLT), meiboscore, meibomian gland dysfunction (MGD), and thyroid antibodies were assessed and data were compared between study participants. RESULTS: The mean OSDI was 40.0 ±5.80 in Group A, which significantly differed from Group B with a mean of 26.5 ±5.10 (p=0.02). There were significant differences between the two groups regarding palpebral fissure height (p=0.02), amount of proptosis (p=0.008), and degree of lagophthalmos (p=0.001). Similarly, active TED patients had more decreased tear secretion than inactive TED patients (p=0.012). Moreover, active TED patients showed a significant increase in Meibomian gland loss areas in both upper and lower eyelids compared with inactive TED patients (p=0.001). Corneal fluorescein staining also revealed a statistically significant difference between the studied groups (p=0.0001). CONCLUSION: This study showed differences regarding ocular surface parameter changes between both active and inactive TED and compared to controls. Further studies are needed to confirm these results.
format Online
Article
Text
id pubmed-8214558
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82145582021-06-22 Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study Allam, Ibrahim Y Lazreg, Sihem Shafik Shaheen, Mohamed Doheim, Mohamed Fahmy Mohammed, Mai A Clin Ophthalmol Original Research BACKGROUND: This study aimed to compare ocular surface parameter changes in active and inactive thyroid eye disease (TED) patients and controls. METHODS: This is an observational clinical study that included 60 eyes divided into three groups following clinical activity score (CAS) assessment. The first group (Group A) comprised 20 eyes with active TED (CAS score ≥3/7), while the second group (Group B) comprised 20 eyes with inactive TED (CAS score <3/7) and the third group (Group C) comprised 20 eyes of controls without dry eye manifestations. The palpebral fissure height, degree of proptosis, degree of lagophthalmos, ocular surface disease index (OSDI), Schirmer test without anesthesia, corneal fluorescein staining (CFS), non-invasive tear break-up time (NITBUT), tear meniscus height (TMH), lipid layer thickness (LLT), meiboscore, meibomian gland dysfunction (MGD), and thyroid antibodies were assessed and data were compared between study participants. RESULTS: The mean OSDI was 40.0 ±5.80 in Group A, which significantly differed from Group B with a mean of 26.5 ±5.10 (p=0.02). There were significant differences between the two groups regarding palpebral fissure height (p=0.02), amount of proptosis (p=0.008), and degree of lagophthalmos (p=0.001). Similarly, active TED patients had more decreased tear secretion than inactive TED patients (p=0.012). Moreover, active TED patients showed a significant increase in Meibomian gland loss areas in both upper and lower eyelids compared with inactive TED patients (p=0.001). Corneal fluorescein staining also revealed a statistically significant difference between the studied groups (p=0.0001). CONCLUSION: This study showed differences regarding ocular surface parameter changes between both active and inactive TED and compared to controls. Further studies are needed to confirm these results. Dove 2021-06-15 /pmc/articles/PMC8214558/ /pubmed/34163131 http://dx.doi.org/10.2147/OPTH.S317708 Text en © 2021 Allam et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Allam, Ibrahim Y
Lazreg, Sihem
Shafik Shaheen, Mohamed
Doheim, Mohamed Fahmy
Mohammed, Mai A
Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
title Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
title_full Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
title_fullStr Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
title_full_unstemmed Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
title_short Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
title_sort ocular surface changes in patients with thyroid eye disease: an observational clinical study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214558/
https://www.ncbi.nlm.nih.gov/pubmed/34163131
http://dx.doi.org/10.2147/OPTH.S317708
work_keys_str_mv AT allamibrahimy ocularsurfacechangesinpatientswiththyroideyediseaseanobservationalclinicalstudy
AT lazregsihem ocularsurfacechangesinpatientswiththyroideyediseaseanobservationalclinicalstudy
AT shafikshaheenmohamed ocularsurfacechangesinpatientswiththyroideyediseaseanobservationalclinicalstudy
AT doheimmohamedfahmy ocularsurfacechangesinpatientswiththyroideyediseaseanobservationalclinicalstudy
AT mohammedmaia ocularsurfacechangesinpatientswiththyroideyediseaseanobservationalclinicalstudy